Loading clinical trials...
Loading clinical trials...
A Phase 1, Single-Center, Repeat-Dose, Open-Label, Fixed-Sequence Drug-Drug Interaction Study of ZX008 in Healthy Male Or Female Study Participants 18 To 55 Years Of Age
Conditions
Interventions
midazolam
metformin
+2 more
Locations
1
United States
Up0132 1001
Baltimore, Maryland, United States
Start Date
December 4, 2024
Primary Completion Date
June 12, 2025
Completion Date
June 12, 2025
Last Updated
March 30, 2026
NCT05845645
NCT04867642
NCT05292131
NCT04828343
NCT04444466
NCT04136444
Lead Sponsor
UCB BIOSCIENCES, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions